Lowther S, De Paermentier F, Crompton M R, Katona C L, Horton R W
Department of Pharmacology and Clinical Pharmacology, St. George's Hospital Medical School, London, UK.
Brain Res. 1994 Apr 11;642(1-2):281-9. doi: 10.1016/0006-8993(94)90932-6.
5-HT2 binding sites were quantitated, by saturation binding with [3H]ketanserin, in six brain regions from 73 subjects who died by suicide and 70 sudden death controls. There were no significant differences in the number of 5-HT2 binding sites between suicides and controls in any brain region within the total suicide group or when suicides were divided on the basis of violence of death. Similar results were found when suicides were divided into those with a firm retrospective diagnosis of depression, whether they had been receiving antidepressants or not, and those who were heterogeneous in respect of psychiatric diagnosis and drug treatment. The present findings contrast with previous reports of higher cortical 5-HT2 binding sites in suicides; possible reasons for these differences are discussed.
通过用[3H]酮色林进行饱和结合,对73例自杀死亡者和70例猝死对照者的六个脑区中的5-HT2结合位点进行了定量分析。在整个自杀组的任何脑区中,以及根据死亡暴力程度对自杀者进行分类时,自杀者和对照者之间的5-HT2结合位点数量均无显著差异。当将自杀者分为有明确的抑郁症回顾性诊断者(无论是否接受过抗抑郁药治疗)以及精神诊断和药物治疗情况各异者时,也发现了类似结果。本研究结果与先前关于自杀者皮质5-HT2结合位点较高的报道形成对比;讨论了这些差异的可能原因。